SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001169245-23-000014
Filing Date
2023-04-03
Accepted
2023-04-03 16:05:09
Documents
5
Period of Report
2022-12-31
Effectiveness Date
2023-04-03

Document Format Files

Seq Description Document Type Size
1 NT 10-K phasebio-nt10xk2022final.htm NT 10-K 11896
2 phasebio-nt10xk2022final001.jpg GRAPHIC 107967
3 phasebio-nt10xk2022final002.jpg GRAPHIC 169467
4 phasebio-nt10xk2022final003.jpg GRAPHIC 305621
5 phasebio-nt10xk2022final004.jpg GRAPHIC 87088
  Complete submission text file 0001169245-23-000014.txt   936416
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-38697 | Film No.: 23792594
SIC: 2834 Pharmaceutical Preparations